New drug aims to stop cancer wasting
Symptom relief
Recruiting now
This Phase 2 trial tests a drug called ASCA101 in 135 adults with solid tumors (colorectal, ovarian, or lung cancer) who have cachexia—a condition causing severe weight loss and muscle wasting. Participants receive either ASCA101, an active control (Megace), or a placebo for 12 w…
Phase: PHASE2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC